000 | 01200 a2200313 4500 | ||
---|---|---|---|
005 | 20250514045957.0 | ||
264 | 0 | _c20030221 | |
008 | 200302s 0 0 eng d | ||
022 | _a0340-6199 | ||
024 | 7 |
_a10.1007/s00431-002-1017-6 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVisser, Gepke | |
245 | 0 | 0 |
_aConsensus guidelines for management of glycogen storage disease type 1b - European Study on Glycogen Storage Disease Type 1. _h[electronic resource] |
260 |
_bEuropean journal of pediatrics _cOct 2002 |
||
300 |
_aS120-3 p. _bdigital |
||
500 | _aPublication Type: Guideline; Journal Article; Practice Guideline; Review | ||
650 | 0 | 4 |
_aGlycogen Storage Disease Type I _xcomplications |
650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xadministration & dosage |
650 | 0 | 4 | _aHumans |
700 | 1 | _aRake, Jan Peter | |
700 | 1 | _aLabrune, Philippe | |
700 | 1 | _aLeonard, James V | |
700 | 1 | _aMoses, Shimon | |
700 | 1 | _aUllrich, Kurt | |
700 | 1 | _aWendel, Udo | |
700 | 1 | _aSmit, G Peter A | |
773 | 0 |
_tEuropean journal of pediatrics _gvol. 161 Suppl 1 _gp. S120-3 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00431-002-1017-6 _zAvailable from publisher's website |
999 |
_c12183372 _d12183372 |